JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knaapen, P.
Right arrow Articles by Visser, F. C.

Perfusable Tissue Index as a Potential Marker of Fibrosis in Patients with Idiopathic Dilated Cardiomyopathy

Paul Knaapen, MD1, Ronald Boellaard, PhD2, Marco J.W. Götte, MD, PhD1, Pieter A. Dijkmans, MD1, Linda M.C. van Campen, MD1, Carel C. de Cock, MD, PhD1, Gert Luurtsema, BSc2, Cees A. Visser, MD, PhD1, Adriaan A. Lammertsma, PhD2 and Frans C. Visser, MD, PhD1

1 Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands
2 PET Center, VU University Medical Center, Amsterdam, The Netherlands



View larger version (58K):

[in a new window]
 
FIGURE 1. Short-axis ATF (A) and PTF (B) images of a healthy volunteer. Arrow in PTF image indicates inferior wall. Spillover effects from adjacent liver tissue are present.

 


View larger version (7K):

[in a new window]
 
FIGURE 2. PTI for healthy control subjects and DCM patients.

 


View larger version (7K):

[in a new window]
 
FIGURE 3. ATF (A) and PTF (B) for healthy control subjects and DCM patients.

 


View larger version (11K):

[in a new window]
 
FIGURE 4. Frequency distributions (percentage of left ventricle) of normalized MBF (A) and PTI (B) for both healthy control subjects (solid lines) and DCM patients (dashed lines). COVs were increased for MBF and PTI in DCM patients compared with COVs for control subjects, indicating increased heterogeneity (P < 0.05).

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.